For instance, a 37-year-old female patient with both Rheumatoid Arthritis (RA) and myasthenia gravis (MG) achieved complete remission of MG and a significant reduction in RA disease activity following CD19-CAR T therapy (22). Here, CD19 is linked to rheumatoid arthritis.